| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |